FDA Inspection 1169701 — Beijing Yiling Bio-engineering Technology Co., Ltd.
The FDA completed an inspection of Beijing Yiling Bio-engineering Technology Co., Ltd. on April 15, 2022 in Miyun. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- April 15, 2022
- Fiscal Year
- 2022
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Miyun (China)